XNAS: CGEM
Cullinan Oncology Inc Live Stock Price Today, Share Analysis and Chart
about
Cullinan Therapeutics Inc is a clinical-stage biopharmaceutical company developing therapies for autoimmune diseases and cancer. Its development pipeline comprises the following drug candidates: CLN-978, a CD19xCD3 bispecific T cell engager that is b...
Read More
17.69
1.28
(7.80%)
594.7K
XNAS Volume
XNAS 17 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Cullinan Oncology Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..